Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Plunkett Research, Ltd.
|
$99.00
|
|
Provider: Plunkett Research, Ltd.
|
$99.00
|
|
Provider: Plunkett Research, Ltd.
|
$99.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Bristol-Myers Squibb Co Announces Dividend
Bristol-Myers Squibb Co announced that its Board of Directors declared a quarterly dividend of $0.35 per share on the $0.10 par value Common Stock of the corporation. The quarterly dividend will be payable on May 1, 2013, to stockholders of record at the close of business on April 5, 2013. The Directors also declared a quarterly dividend of $0.50)per share on the $2.00 Convertible Preferred Stock of the corporation, payable June 3, 2013, to stockholders of record at the close of business on May 10, 2013.
Latest Developments for Bristol-Myers Squibb Co
- Bristol-Myers Squibb Co Receives US FDA sNDA Approval For Use Of SUSTIVA (efavirenz) In HIV-1 Infected Pediatric Patients
- Bristol-Myers Squibb Co Reaffirms FY 2013 EPS Guidance
- Bristol-Myers Squibb Co's and Sanofi SA's Plavix to Be Investigated by U.S. Department of Justice-Reuters
- UK Cost Agency Rejects Drugs From Bristol-Myers Squibb Co, Roche Holding AG And AstraZeneca PLC-Reuters
Latest Key Developments in Pharmaceuticals
- Share this
- Link this
- Digg this


Follow Reuters